MGMT and neoplasm: Brandes et al. [31] reviewed 95 patients treated with high dose radiotherapy who showed an infield or marginal recurrence rate of 85% in unmethylated MGMT tumours, compared with 57.9% of patients with methylated tumours; with failures out of field presenting at significantly longer time intervals to those with in field failures.